Abstract:Objective To study the effect of atorvastatin on matrix metalloproteinase 9(MMP-9) expression in the upstream shoulder(proximal end) of aortic atherosclerotic plaques in rabbits.Methods Thirty male New Zealand rabbits were randomized into normal control group(n=9),high-lipid diet group(n=11) and atorvastatin group(n=10).An aortic atherosclerotic model was induced by high-lipid diet in the last two groups.From the ninth week,the high-lipid diet group rabbits were administered starch 1.5 mg/kg body weight per day,and the rabbits of atorvastatin group were administered atorvastatin 1.5 mg/kg body weight per day.After the rabbits were killed,the gross specimen of aorta was observed,and the rabbits whose intimal hyperplasia complicated with the formation of atherosclerotic plaque were regarded as the successful induction of the model.The percentage of macrophage and smooth muscle cell positive area in the upstream shoulder of plaques and the expression of MMP-9 were detected by immunohistochemistry methods.Results The formation of neointima was seen in aorta in the high-lipid diet and atorvastation groups,the ratios of intima-media thickness were 1.41±0.34 and 0.63±0.12,respectively.The distribution sites of macrophages in the plaques were in concordance with the region of positive expression of MMP-9,and they were all assembled at the upstream shoulder of the plaques.As compared with the high-lipid diet group,atorvastatin reduced aggregation of macrophages significantly(the percentages of positive areas were 26.5%±4.3% and 12.4%±1.5%,respectively) and expression of MMP-9(the values of optical density were 0.081±0.014 and 0.022±0.004,respectively) in the upstream shoulders of the aortic plaques.There were significant differences between the two groups(P<0.01).The percentages of positive areas of smooth muscle cells in the high-lipid diet and atorvastatin groups were 47.2%±12.3% and 50.4%±10.8%,respectively.There were no significant differences between the two groups(P>0.05).Conclusions The macrophages in the atherosclerotic plaque and the expressions of MMP-9 are mainly in the upstream shoulder.Atorvastatin may significantly reduce the aggregation of macrophages and the expression of MMP-9 in this area.

Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits.

Atorvastatin Improves Cardiac Lipid Metabolism in Spontaneous Hypertensive Rats and Ameliorates Cardiac Hypertrophy

Effects of Atorvastatin on Myocardium Expression of Peroxisome Proliferator-Activated Receptors in Spontaneously Hypertensive Rats

Combined effects of atorvastatin and soybean isoflavones on hypercholesterolemia and lipoprotein metabolism

[Effects of Atorvastatin on P27 Protein Expression and Cardiomyocytes Apoptosis in Spontaneously Hypertensive Rats].

Tissue-specific Effects of Atorvastatin on 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expression and Activity in Spontaneously Hypertensive Rats

Effect of Atorvastatin on HMG -Coa Reductase Expression in Spontaneously Hypertensive Rats

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

Atorvastatin Decreased Low Density Lipoprotein Level and Improved Coronary Artery Lesion in Patients after Percutaneous Coronary Intervention

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.

Ascorbic Acid Enhances Low-Density Lipoprotein Receptor Expression by Suppressing Proprotein Convertase Subtilisin/kexin 9 Expression.

Effects of Atorvastatin on Bile Acid Metabolism in High-Fat Diet-Fed ApoE-/- Mice

Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy

Overexpression of retinoid X receptor beta provides protection against oxidized low-density lipoprotein-induced inflammation via regulating PGC1α-dependent mitochondrial homeostasis in endothelial cells

Atorvastatin Ester Regulates Lipid Metabolism in Hyperlipidemia Rats via the PPAR-signaling Pathway and HMGCR Expression in the Liver

Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study

Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway

Atorvastatin Represses the Angiotensin 2-Induced Oxidative Stress and Inflammatory Response in Dendritic Cells Via the PI3K/Akt/Nrf 2 Pathway

Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3p

Effect of atorvastatin on matrix metalloproteinase 9 expression in the upstream shoulder of aortic atherosclerotic plaques in rabbits

Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome